Cargando…
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial
OBJECTIVES: Primary Objective: To evaluate the efficacy and safety of oral administration of imatinib combined with the Best Conventional Care (BCC) versus placebo plus BCC in hospitalized patients with COVID-19. Hypothesis: Addition of imatinib to the BCC will provide a superior clinical outcome fo...
Autores principales: | Emadi, Ashkan, Chua, Joel V., Talwani, Rohit, Bentzen, Søren M., Baddley, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594416/ https://www.ncbi.nlm.nih.gov/pubmed/33115543 http://dx.doi.org/10.1186/s13063-020-04819-9 |
Ejemplares similares
-
Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
por: Samimagham, Hamid Reza, et al.
Publicado: (2021) -
The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
por: Samimagham, Hamid Reza, et al.
Publicado: (2020) -
Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial
por: Olagunju, Adeniyi, et al.
Publicado: (2021) -
The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
por: Rahimi, Arash, et al.
Publicado: (2021) -
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial
por: Rilinger, Jonathan, et al.
Publicado: (2020)